RU99107569A - Фармацевтические композиции, обладающие антимикробной активностью - Google Patents
Фармацевтические композиции, обладающие антимикробной активностьюInfo
- Publication number
- RU99107569A RU99107569A RU99107569/14A RU99107569A RU99107569A RU 99107569 A RU99107569 A RU 99107569A RU 99107569/14 A RU99107569/14 A RU 99107569/14A RU 99107569 A RU99107569 A RU 99107569A RU 99107569 A RU99107569 A RU 99107569A
- Authority
- RU
- Russia
- Prior art keywords
- antimicrobial activity
- pharmaceutical compositions
- zinc
- complex
- compositions possessing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 3
- 230000000845 anti-microbial Effects 0.000 title claims 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims 3
- 229910052803 cobalt Inorganic materials 0.000 claims 3
- 239000010941 cobalt Substances 0.000 claims 3
- 229940014041 hyaluronate Drugs 0.000 claims 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 3
- 229910052725 zinc Inorganic materials 0.000 claims 3
- 239000011701 zinc Substances 0.000 claims 3
- 208000000718 Duodenal Ulcer Diseases 0.000 claims 2
- 241000590002 Helicobacter pylori Species 0.000 claims 2
- 229940037467 Helicobacter pylori Drugs 0.000 claims 2
- 208000007107 Stomach Ulcer Diseases 0.000 claims 2
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 230000001580 bacterial Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
Claims (3)
1. Применение ассоциата (комплекса) гиалуроната цинка или кобальта для получения фармацевтической композиции, обладающей антимикробной активностью.
2. Применение ассоциата (комплекса) гиалуроната цинка или кобальта в качестве средства для лечения анаэробных бактериальных и/или грибковых инфекций также как желудочных и дуоденальных язв, вызванных Helicobacter pylori.
3. Способ предупреждения повторного инфицирования после лечения желудочных и дуоденальных язв, вызванных Helicobacter pylori, который включает назначение пациенту одной или более эффективной (ых) дозы (доз) соединения (комплекса) гиалуроната цинка или кобальта отдельно или в форме фармацевтической композиции.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP9602498 | 1996-09-12 | ||
HU9602498A HU225329B1 (en) | 1996-09-12 | 1996-09-12 | Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity |
Publications (2)
Publication Number | Publication Date |
---|---|
RU99107569A true RU99107569A (ru) | 2001-02-20 |
RU2204394C2 RU2204394C2 (ru) | 2003-05-20 |
Family
ID=89994266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99107569/14A RU2204394C2 (ru) | 1996-09-12 | 1997-09-11 | Средство для лечения грибковых инфекций, а также желудочных и дуоденальных язв, вызванных helicobacter pylori |
Country Status (15)
Country | Link |
---|---|
US (1) | US6348190B1 (ru) |
EP (1) | EP0964687B1 (ru) |
JP (2) | JP2001500860A (ru) |
KR (1) | KR100489494B1 (ru) |
CN (1) | CN1130204C (ru) |
AT (1) | ATE254922T1 (ru) |
AU (1) | AU4469197A (ru) |
DE (1) | DE69726457T2 (ru) |
DK (1) | DK0964687T3 (ru) |
ES (1) | ES2212131T3 (ru) |
HU (1) | HU225329B1 (ru) |
PT (1) | PT964687E (ru) |
RU (1) | RU2204394C2 (ru) |
UA (1) | UA66766C2 (ru) |
WO (1) | WO1998010773A1 (ru) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU225991B1 (en) * | 1997-04-29 | 2008-02-28 | Richter Gedeon Nyrt | Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer |
GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
ITPD980168A1 (it) * | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara |
CA2359292A1 (en) * | 1999-01-19 | 2000-07-27 | Stericon, L.L.C. | Hypertonic aqueous solutions of polybasic acid salts |
GB0012487D0 (en) * | 2000-05-24 | 2000-07-12 | Pfylori Limited | Use of metal compounds to treat gastrointestinal infections |
FI20011403A (fi) | 2001-06-29 | 2002-12-30 | Carbion Oy | Menetelmä ja koostumukset vatsan sairauksien hoitoon |
US8512761B2 (en) | 2006-01-27 | 2013-08-20 | Yale University | Fast acting inhibitor of gastric acid secretion |
CN103463096B (zh) * | 2006-01-27 | 2016-03-16 | 耶鲁大学 | 胃酸分泌的快速作用抑制剂 |
US8557574B2 (en) * | 2006-02-10 | 2013-10-15 | Seikagaku Corporation | Fungal growth inhibitor |
US20070212420A1 (en) * | 2006-03-10 | 2007-09-13 | Bausch & Lomb Incorporated | Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives |
ITMI20061132A1 (it) * | 2006-06-13 | 2007-12-14 | Sinclair Pharmaceuticals Ltd | Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali |
WO2008036855A2 (en) * | 2006-09-21 | 2008-03-27 | Alcon Research, Ltd. | Self-preserved aqueous pharmaceutical compositions |
TWI394564B (zh) * | 2006-09-21 | 2013-05-01 | Alcon Res Ltd | 自行保存型水性藥學組成物 |
EP2066300B2 (en) * | 2006-09-28 | 2019-01-23 | Novartis Ag | Self-preserved aqueous pharmaceutical compositions |
TWI544927B (zh) * | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
JP5583111B2 (ja) * | 2008-03-17 | 2014-09-03 | アルコン リサーチ, リミテッド | ボレート−ポリオール錯体を含有する水性薬学的組成物 |
TWI489997B (zh) * | 2009-06-19 | 2015-07-01 | Alcon Res Ltd | 含有硼酸-多元醇錯合物之水性藥學組成物 |
TWI383796B (zh) * | 2009-08-14 | 2013-02-01 | Holy Stone Healthcare Co Ltd | Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer |
HUP0900717A3 (en) * | 2009-11-18 | 2012-02-28 | Richter Gedeon Nyrt | Pharmaceutical composition for urological use containing zinc hyaluronate |
JP6081173B2 (ja) * | 2011-12-12 | 2017-02-15 | ロート製薬株式会社 | 眼科用水性組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4623539A (en) | 1983-02-04 | 1986-11-18 | Tunc Deger C | Nutrient barrier polysaccharide compositions and method of use |
EP0259485A4 (en) * | 1986-03-14 | 1988-07-29 | Bio Technology General Corp | HEAVY METAL SALTS OF HYALURONIC ACID FOR USE AS AN ANTIMICROBIAL AGENT. |
US5472950A (en) * | 1989-02-24 | 1995-12-05 | Richter Gedeon Vegyeszeti Gyar Rt. | Compositions containing cobalt hyaluronic acid complex |
HU203372B (en) * | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
JPH0648950A (ja) * | 1992-07-30 | 1994-02-22 | Taito Kk | 抗潰瘍剤 |
-
1996
- 1996-09-12 HU HU9602498A patent/HU225329B1/hu unknown
-
1997
- 1997-09-11 JP JP10513414A patent/JP2001500860A/ja active Pending
- 1997-09-11 ES ES97943084T patent/ES2212131T3/es not_active Expired - Lifetime
- 1997-09-11 KR KR10-1999-7002117A patent/KR100489494B1/ko active IP Right Grant
- 1997-09-11 RU RU99107569/14A patent/RU2204394C2/ru active
- 1997-09-11 PT PT97943084T patent/PT964687E/pt unknown
- 1997-09-11 DE DE69726457T patent/DE69726457T2/de not_active Expired - Lifetime
- 1997-09-11 DK DK97943084T patent/DK0964687T3/da active
- 1997-09-11 UA UA99041975A patent/UA66766C2/ru unknown
- 1997-09-11 AT AT97943084T patent/ATE254922T1/de active
- 1997-09-11 US US09/254,386 patent/US6348190B1/en not_active Expired - Lifetime
- 1997-09-11 WO PCT/HU1997/000052 patent/WO1998010773A1/en active IP Right Grant
- 1997-09-11 AU AU44691/97A patent/AU4469197A/en not_active Abandoned
- 1997-09-11 EP EP97943084A patent/EP0964687B1/en not_active Expired - Lifetime
- 1997-09-11 CN CN97197886A patent/CN1130204C/zh not_active Expired - Lifetime
-
2009
- 2009-02-25 JP JP2009042896A patent/JP2009114206A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU99107569A (ru) | Фармацевтические композиции, обладающие антимикробной активностью | |
CA2140106A1 (en) | Method of treating hyperproliferative vascular disease | |
WO2001072721A3 (en) | Synergistic methods and compositions for treating cancer | |
GEP20012578B (en) | (54) Heteroaryl Succinamides, Pharmaceutical Compositions Containing the Same and Methods for Treatment of the Diseases Caused by Metalloproteinase Activity | |
CA2370030A1 (en) | Sodium channel blocker compositions and the use thereof | |
EP2767291A3 (en) | Treatment of glycogen storage disease type II | |
HK1094191A1 (en) | Phenyl-carboxamide compounds useful for treating pain | |
AU2905092A (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
FI963232A0 (fi) | Antimikrobisena aineena käytettävä hapotettu nitriitti | |
CA2180535A1 (en) | A method for treatment of psoriasis, by omeprazole or related compounds | |
CA2108903A1 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
BG103947A (en) | Derivatives of 9-oxymerythromycin | |
CA2388939A1 (en) | Therapeutic treatments for blood cell deficiencies | |
WO2004011477A3 (en) | 6,11-4-carbon bridged ketolides | |
CA2121345A1 (en) | Lipophilic Oligosaccharide Antibiotic Salt Compositions | |
CA2284774A1 (en) | Theobromine antitussive compositions | |
BG104434A (en) | 2-halo-6-o-substituted ketolide derivatives | |
EE04953B1 (et) | Tsinkhaluronaadi kasutamine ja meetod ravimkoostise valmistamiseks | |
AU4830097A (en) | Use of an extract of Cimicifuga | |
DE69927584D1 (de) | Pharmazeutische zubereitungen zur behandlung von magengeschwüren | |
DE69521536T2 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
EP0281070A3 (en) | Pharmaceutical composition for the treatment of cancer | |
PL313078A1 (en) | Novel bis-naphtalimides for use in treating carcinoma | |
NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
WO1998006265A3 (en) | Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine |